Stockreport

Foghorn Therapeutics to Participate in the BMO Oncology Summit

Foghorn Therapeutics Inc.  (FHTX) 
PDF CAMBRIDGE, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicin [Read more]